PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 79 filers reported holding PUMA BIOTECHNOLOGY INC in Q1 2023. The put-call ratio across all filers is 0.15 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $776 | -23.9% | 295 | +2.1% | 0.00% | – |
| Q2 2023 | $1,020 | +21.4% | 289 | +6.2% | 0.00% | – |
| Q1 2023 | $840 | -25.6% | 272 | +1.9% | 0.00% | – |
| Q4 2022 | $1,129 | +12.9% | 267 | +2.7% | 0.00% | – |
| Q3 2022 | $1,000 | 0.0% | 260 | +2.8% | 0.00% | – |
| Q2 2022 | $1,000 | -99.8% | 253 | -99.8% | 0.00% | – |
| Q1 2022 | $404,000 | -38.4% | 140,495 | -34.9% | 0.00% | – |
| Q4 2021 | $656,000 | -63.6% | 215,768 | -16.1% | 0.00% | – |
| Q3 2021 | $1,802,000 | -12.6% | 257,025 | +14.5% | 0.00% | – |
| Q2 2021 | $2,062,000 | -2.7% | 224,470 | +2.9% | 0.00% | – |
| Q1 2021 | $2,120,000 | +154.5% | 218,156 | +168.9% | 0.00% | – |
| Q4 2020 | $833,000 | -19.0% | 81,140 | -20.4% | 0.00% | – |
| Q3 2020 | $1,028,000 | +7.6% | 101,888 | +11.3% | 0.00% | – |
| Q2 2020 | $955,000 | +24.3% | 91,504 | +0.5% | 0.00% | – |
| Q1 2020 | $768,000 | +2.3% | 91,068 | +6.1% | 0.00% | – |
| Q4 2019 | $751,000 | -13.8% | 85,802 | +6.2% | 0.00% | – |
| Q3 2019 | $871,000 | +4.3% | 80,796 | +22.9% | 0.00% | – |
| Q2 2019 | $835,000 | -2.7% | 65,717 | +196.9% | 0.00% | – |
| Q1 2019 | $858,000 | +89.0% | 22,131 | -0.6% | 0.00% | – |
| Q4 2018 | $454,000 | -56.6% | 22,267 | -2.3% | 0.00% | – |
| Q3 2018 | $1,045,000 | -30.6% | 22,783 | -10.5% | 0.00% | – |
| Q2 2018 | $1,506,000 | -93.5% | 25,451 | -92.6% | 0.00% | -100.0% |
| Q1 2018 | $23,309,000 | -55.1% | 342,515 | -34.8% | 0.01% | -53.3% |
| Q4 2017 | $51,890,000 | +640.2% | 524,933 | +796.5% | 0.02% | +650.0% |
| Q3 2017 | $7,010,000 | +248.6% | 58,551 | +154.5% | 0.00% | +100.0% |
| Q2 2017 | $2,011,000 | +123.7% | 23,010 | -4.7% | 0.00% | – |
| Q1 2017 | $899,000 | +33.2% | 24,151 | +10.0% | 0.00% | – |
| Q4 2016 | $675,000 | -11.1% | 21,950 | +94.0% | 0.00% | – |
| Q3 2016 | $759,000 | +193.1% | 11,315 | +30.1% | 0.00% | – |
| Q2 2016 | $259,000 | +259.7% | 8,700 | +255.7% | 0.00% | – |
| Q1 2016 | $72,000 | -58.9% | 2,446 | +9.6% | 0.00% | – |
| Q4 2015 | $175,000 | +3.6% | 2,232 | -0.7% | 0.00% | – |
| Q3 2015 | $169,000 | -98.2% | 2,248 | -97.3% | 0.00% | -100.0% |
| Q2 2015 | $9,411,000 | -89.8% | 82,571 | -78.9% | 0.00% | -77.8% |
| Q1 2015 | $92,570,000 | +41.1% | 392,070 | +13.1% | 0.02% | -30.8% |
| Q4 2014 | $65,592,000 | -48.2% | 346,552 | -34.7% | 0.03% | -50.9% |
| Q3 2014 | $126,704,000 | +323.2% | 531,102 | +17.1% | 0.05% | +341.7% |
| Q2 2014 | $29,936,000 | -15.0% | 453,586 | +34.2% | 0.01% | -20.0% |
| Q1 2014 | $35,208,000 | +21.0% | 338,082 | +20.3% | 0.02% | +15.4% |
| Q4 2013 | $29,088,000 | +69.6% | 280,968 | -12.1% | 0.01% | +62.5% |
| Q3 2013 | $17,154,000 | +171440.0% | 319,683 | +141981.3% | 0.01% | – |
| Q2 2013 | $10,000 | – | 225 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Athyrium Capital Management, LP | 1,792,114 | $5,108,000 | 2.15% |
| Camber Capital Management LP | 4,235,000 | $12,070,000 | 0.52% |
| Kynam Capital Management, LP | 579,915 | $1,653,000 | 0.42% |
| GLOBEFLEX CAPITAL L P | 419,322 | $1,195,000 | 0.29% |
| Eversept Partners, LP | 1,435,077 | $4,089,969 | 0.29% |
| ARMISTICE CAPITAL, LLC | 1,500,000 | $4,275,000 | 0.08% |
| RICE HALL JAMES & ASSOCIATES, LLC | 506,066 | $1,442,000 | 0.07% |
| XTX Topco Ltd | 36,130 | $103,000 | 0.04% |
| State of Wyoming | 20,732 | $59,000 | 0.04% |
| Patriot Financial Group Insurance Agency, LLC | 55,500 | $158,000 | 0.03% |